Tagged with Trend

Is 2022 the Pharma Industry’s ‘Call of Duty’ Moment?
Further Predictions for 2019 – Tech, Value-Based Pricing & Emerging Markets
Interview: Rami El-Cheikh – National Pharma & Life Sciences Leader, PwC Canada
Interview: Rafael Gual Cosío – Director General, CANIFARMA, Mexico
Interview: Anne-Christine Marie – Partner in charge of the Pharma and Life sciences Division, PwC France
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here